相关实验视频

Updated: Jan 8, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

相互排斥分析表明,DUSP9负面调节PD-L1表达,并作为增强抗PD-1效率的目标

Yuzhe Hu^1,2, Ling Tang^1,2, Zheng Kuang^1,2

¹Department of Immunology, NHC Key Laboratory of Medical Immunology (Peking University), Medicine Innovation Center for Fundamental Research on Major Immunology-related Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

|December 17, 2025

概括

双特异性酸酶9 (DUSP9) 被确定为PD-L1表达的负调节剂. 将DUSP9与PD-1抗体相结合的向可能会提高癌症免疫治疗的疗效,并预测患者的反应.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

编程死亡连接体1 (PD-L1) 表达是免疫检查点阻塞 (ICB) 疗法疗效的关键预测因子.
缺乏使用相互排斥 (ME) 基因表达分析对PD-L1调节的系统探索.

研究的目的:

通过ME分析识别PD-L1表达的新型负调节剂.
研究双特异性酸酶9 (DUSP9) 在调节PD-L1中的作用及其作为癌症免疫疗法治疗标的潜力.

主要方法:

相互排斥 (ME) 基因表达分析以确定PD-L1.1的负调节者.
在瘤细胞中的体外研究以阐明DUSP9作用机制.
综合性瘤模型和临床数据分析,以评估治疗疗效和预测潜力.

主要成果:

确定了PD-L1的多个负调节剂,并选择了DUSP9进行进一步研究.
发现DUSP9通过去酸化STAT3.3来负面调节瘤细胞中的PD-L1表达.
针对DUSP9和PD-1抗体的组合疗法在临床前模型中增强了治疗敏感性.
在临床数据中,高DUSP9表达与PD-1/PD-L1抗体治疗的响应率降低相关.

结论:

DUSP9通过STAT3脱化作用作为PD-L1表达的负调节剂.
DUSP9是提高ICB疗效的潜在治疗标,也是免疫治疗反应的预测生物标志物.
ME分析方法对于识别高度可塑性基因的负调节剂和组合免疫治疗的潜在点是有效的.

关键词:

在DUSP9中,使用的是DUSP9.在PD-L1中.在STAT3中,我们可以使用STAT3.组合疗法治疗组合治疗.免疫检查点封锁 (ICB)相互排斥干扰 (MEi) 战略

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Negative Regulator Molecules

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.